Interpretive Summaries, June 2021

Research Summaries - June 2005

Summaries of safety labeling changes approved by FDA-boxed warnings highlights March-June 2016.

Class of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), includes Anaprox (naproxen), Ansaid (flurbiprofen), Arthrotec (diclofenac sodium/misoprostil), Caldolor (ibuprofen), Cambia (diclofenac potassium), Cataflam (diclofenac), Celebrex (celecoxib), Daypro (oxaprozin), Daypro Alta (oxaprozin), Duexis (ibuprofen and famotidine), Dyloject (diclofenac), Feldene (piroxicam), Flector (diclofenac), In...

EMBL Programme 2017-2021: Digital Biology

Summaries ∗

Current techniques for validating and verifying program changes often consider the entire program, even for small changes, leading to enormous V&V costs over a program’s lifetime. This is due, in large part, to the use of syntactic program differencing techniques which are necessarily imprecise. Building on recent advances in symbolic execution of heap manipulating programs, in this paper, we d...

Interpretive Summary

The Office of Public Health and Science in the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA/FSIS)—with input from other federal agencies, industry, and the public—conducted an assessment of the risk of illness associated with Escherichia coli O157:H7 in ground beef. This risk assessment details our current state of knowledge about (1) the occurrence of E. coli O157:...